David Brayden
Professor of Advanced Drug Delivery University College Dublin
David Brayden is a Full Professor of Advanced Drug Delivery at University College Dublin (UCD) David is a pharmacologist who obtained his PhD from the University of Cambridge, (UK) followed by a postdoctoral fellowship at Stanford University, CA, USA. He spent 10 years as a senior scientist at Elan Pharmaceuticals from 1991-2001. He is the author or co-author of more than 300 research publications and patents in the areas of oral peptide delivery and nanomedicine. David was elected as a Fellow of the Controlled Release Society (CRS, 2012), the American Association of Pharmaceutical Scientists (AAPS, 2017) and the Royal Irish Academy (2024). He is a co-lead PI on the Research Ireland Centre for Medical Devices (CURAM) (2014-2026). David is the current coordinator of BUCCAL-PEP, an EU Horizon Europe grant on buccal administration of peptides. In 2021 David was appointed Chief Editor of “Frontiers in Drug Delivery”. In 2024, he was appointed by Ireland’s Minister of Health as a chairperson of Ireland’s National Research Ethics Committee (Clinical Trials).
Seminars
- Reviewing the mechanisms of action of key intestinal permeation enhancers
- Spotlighting clinical development of oral peptide formulations with enhancers
- Re-purposing known excipients as permeation enhancers for oral peptide administration
- How to effectively design patient-centric peptide delivery formulations (oral vs injectable)?
- How to ensure novel peptide formulations can be scalable and cost efficient during the manufacturing process?
- Where will delivery innovations take the peptide field in the next 5 years?
